Published in Nephrol Dial Transplant on October 03, 2014
The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy. Front Immunol (2016) 0.83
Longitudinal monitoring of immunoglobulin A glycosylation during pregnancy by simultaneous MALDI-FTICR-MS analysis of N- and O-glycopeptides. Sci Rep (2016) 0.78
IgA nephropathy enigma. Clin Immunol (2016) 0.75
Inflammation in IgA nephropathy. Pediatr Nephrol (2017) 0.75
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int (2007) 3.17
IgA nephropathy. N Engl J Med (2013) 2.96
Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest (2009) 2.82
A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci U S A (2002) 2.80
Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest (1999) 2.77
Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol (2004) 2.48
The pathophysiology of IgA nephropathy. J Am Soc Nephrol (2011) 2.27
Structure of the carbohydrate units of IgA1 immunoglobulin. II. Structure of the O-glycosidically linked oligosaccharide units. J Biol Chem (1974) 2.17
IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest (2008) 2.15
The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions. J Biol Chem (1998) 2.10
Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int (2001) 2.10
Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int (2001) 1.99
Cloning and expression of human core 1 beta1,3-galactosyltransferase. J Biol Chem (2001) 1.98
Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int (1997) 1.88
Sialyltransferases in cancer. Glycoconj J (2003) 1.83
Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition. J Biol Chem (2010) 1.48
Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1. Mol Cell Proteomics (2009) 1.45
Partial duplication in the "hinge" region of IgA 1 myeloma proteins. Proc Natl Acad Sci U S A (1972) 1.36
Progress in molecular and genetic studies of IgA nephropathy. J Clin Immunol (2001) 1.34
Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen. Cancer Res (2004) 1.23
Clustered O-glycans of IgA1: defining macro- and microheterogeneity by use of electron capture/transfer dissociation. Mol Cell Proteomics (2010) 1.21
O-linked oligosaccharides from human serum immunoglobulin A1. Biochem Soc Trans (1989) 1.17
IgA nephropathy: molecular mechanisms of the disease. Annu Rev Pathol (2012) 1.16
Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2. J Biol Chem (2002) 1.09
Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes. J Biol Chem (2014) 1.06
Naturally occurring structural isomers in serum IgA1 o-glycosylation. J Proteome Res (2011) 1.05
Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cells. J Mol Biol (2007) 1.02
Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens. Glycobiology (1999) 0.95
Aberrant O-glycosylation and anti-glycan antibodies in an autoimmune disease IgA nephropathy and breast adenocarcinoma. Cell Mol Life Sci (2012) 0.89
Evaluation of the possible proteomic application of trypsin from Streptomyces griseus. Anal Biochem (2008) 0.84
Molecular cloning and functional expression of human ST6GalNAc II. Molecular expression in various human cultured cells. Biochim Biophys Acta (2000) 0.84
Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy. PLoS One (2014) 0.82
Pathogenesis of immunoglobulin A nephropathy. Curr Opin Nephrol Hypertens (2013) 0.82
Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing. J Proteomics (2013) 0.80
Production of N-acetylgalactosaminyl-transferase 2 (GalNAc-T2) fused with secretory signal Igκ in insect cells. Protein Expr Purif (2011) 0.80